Core Scientific (CORZ) Equity Average (2021 - 2025)
Historic Equity Average for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$1.1 billion.
- Core Scientific's Equity Average fell 1985.55% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 1985.55%. This contributed to the annual value of -$708.6 million for FY2024, which is 4082.67% down from last year.
- Per Core Scientific's latest filing, its Equity Average stood at -$1.1 billion for Q3 2025, which was down 1985.55% from -$623.1 million recorded in Q2 2025.
- In the past 5 years, Core Scientific's Equity Average ranged from a high of $1.2 billion in Q1 2022 and a low of -$1.1 billion during Q3 2025
- Its 5-year average for Equity Average is -$211.5 million, with a median of -$403.4 million in 2023.
- In the last 5 years, Core Scientific's Equity Average soared by 933141.63% in 2022 and then plummeted by 26572.05% in 2023.
- Core Scientific's Equity Average (Quarter) stood at $645.1 million in 2021, then tumbled by 126.07% to -$168.2 million in 2022, then crashed by 202.0% to -$507.8 million in 2023, then tumbled by 52.57% to -$774.8 million in 2024, then plummeted by 41.5% to -$1.1 billion in 2025.
- Its Equity Average stands at -$1.1 billion for Q3 2025, versus -$623.1 million for Q2 2025 and -$500.8 million for Q1 2025.